ADB-BUTINACA acts as an agonist at CB1 and CB2 receptors, mimicking the results of purely natural cannabinoids. It is commonly used in study to review receptor interactions and their influence on the central anxious system.This compound is intended only for laboratory and forensic study and isn't approved for human or veterinary usage. Suitable man